期刊文献+

慢性肾脏病钙、磷及甲状旁腺激素水平变化的对比分析 被引量:2

Chronic kidney disease in calcium, phosphorus and parathyroid hormone level changes of comparative analysis
原文传递
导出
摘要 目的观察各期慢性肾脏病(CKD)患者的钙、磷及甲状旁腺激素(PTH)水平并分析其临床特征,为早期防治提供依据。方法选择2006年1月至2010年12月在新疆自治区人民医院肾病科住院的CKD患者294例,检测血清磷(P)、钙(Ca)、肌酐(Cr)、血清白蛋白(ALB)、CaP及血清甲状旁腺激素(PTH)的浓度。并进行回顾性分析。结果CKD1~2期患者血清钙、磷与对照组比较无显著性差异。CKD2期患者血清肌酐与对照组比较有显著性差异(P〈0.05)。CKD3~5期患者血清钙浓度低于对照组(P〈0.05),与CKD1~2期比较有差异,CKD5期患者血清钙浓度明显低于CKD3~4期有显著性差异。CKD3~5期患者血磷高于对照组及CKD1~2期,有显著性差异(P〈0.01),血磷增高明显与血钙和PrH有显著性差异(P〈0.05)。CKD2~5期患者血肌酐高于对照组及CKD1期患者有显著性差异(P〈0.01),与各组间比较亦无明显差异。结论对于CKD3期患者我们应该积极给予降低血磷的综合治疗,以防治继发性甲状旁腺功能亢进发生。 Objectives Observe all issues of chronic kidney disease (CKD) patients of calcium, phosphorus and parathyroid hormone(PTH) level, analysis the clinical features, and providing the basis for the early prevention and control. Methods Choose in January 2006 to December 2010 in department of nephropathy of the People Hospital of Xinjiang Uyghur Autonomous Region with CKD of 294 cases in patients, The measurement of serum phosphorus (P), calcium (Ca), creatinine (Cr), serum albumin (ALB), CaP and serum parathyroid hormone (PTH) concentrations. And were retrospectively analyzed. Results By stages CKD1 - 2 patients'serum calcium, phosphorus were compared with control group no significant differences. CKD2 in serum creatinine and control group patients with significant difference ( P 〈 0.05 ). CKD3 -5 patients serum calcium concentration lower than those of the control group (P 〈0.05)have significant difference,And compared with CKD1 -2 there were More differences, CKD5 period patients serum calcium concentration significantly lower than CKD3 - 4 period. CKD3 - 5 patients serum phosphorus higher than those in the control group and CKD1 -2, have Signifieant difference( P 〈 0.01 ), obviously Increased serum phosphorus with the serum calcium and PTH have significant difference ( P 〈 0.05 ). CKD2 - 5 patients serum creatinine higher than those in the control group and CKD1 period patients have significant difference( P 〈 0.01 ), And there were no significant differences between groups. Conclusions For CKD3 period of the patients we should actively take comprehensive treatment of reduce serum phosphorus, prevention and cure to secondary hyperparathyroidism happen.
出处 《国际泌尿系统杂志》 2012年第4期472-474,共3页 International Journal of Urology and Nephrology
关键词 肾疾病 慢性病 甲状旁腺激素类 Kidney Diseases Chronic Disease Calcium Phosphorus Parathyroid Hormones
  • 相关文献

参考文献14

  • 1Panawong W, Chaiyakum A, Pongskul C. Adherence to mineraland bone disorder clinical practice guidelines in chronic kidney disease. J Med Asset Thai ,2011,94 (10) : 1175 - 1183.
  • 2侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.我国五省市、自治区慢性肾脏病患者心血管疾病的危险因素调查[J].中华医学杂志,2005,85(11):753-759. 被引量:26
  • 3Block G A. Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin Nephrol, 2000,54 ( 4 ) : 318 -324.
  • 4全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:729
  • 5Stubbs JR, Wetmore J B. Does it matter how parathyroid hormone levels are suppressed in secondary hyperparathyroidism. Semin Di- al,2011,24(3) :298 -306.
  • 6Block GA. Therapeutic interventions for chronic kidney disease - mineral and bone disorders : focus on mortality [ J ]. Curr Opin Nephrol Hypertens,2011,20(4) :376 -381.
  • 7Lorenzo SV, Torregrosa V. [ Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis) ]. Ne- froloia.2008.28 Sunni 3,67 - 78.
  • 8Moorthi RN, Moe S M. CKD- mineral and bone disorder: core curriculum 2011. Am J Kidney Dis,2011,58 (6) : 1022 - 1036.
  • 9孙鲁英,王梅,杨莉.终末期肾脏病患者钙磷代谢及甲状旁腺激素水平的临床分析[J].北京大学学报(医学版),2005,37(2):147-150. 被引量:64
  • 10Hoy T, Fisher M, Barber B, et al. Adherence to K/DOQI prac- tice guidelines for bone metabolism and disease. Am J Manag Care ,2007,13 ( 11 ) :620 - 625.

二级参考文献43

  • 1张卫茹,侯凡凡,刘尚喜,郭志坚,周展眉,王国保,富宁,刘志强,王力,周玫.晚期糖基化终产物通过氧化应激加速动脉粥样硬化斑块形成[J].中华医学杂志,2004,84(13):1066-1070. 被引量:29
  • 2侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:184
  • 3吴兆苏,姚崇华,赵冬,吴桂贤,王薇,刘静,曾哲淳,吴英恺.我国多省市心血管病趋势及决定因素的人群监测(中国MONICA方案)Ⅰ.发病率和死亡率监测结果[J].中华心血管病杂志,1997,25(1):6-11. 被引量:205
  • 4Lemann JJ, Litzow JR, Lennon EJ. The effect of chronic acid loads in normal man: Further evidence against chronic metabolic acidosis[J]. J Clin Invest, 1966, 45:1608-1614
  • 5Lemann JJ, Litzow JR, Lennon EJ. Studies of the mechanism by which chronic metabolic acidosis augment urinary calcium excretion in man[J]. J Clin Invest, 1967, 46:1318-1328
  • 6Craig BL. Calcitriol metabolism during chronic metabolic acidosis[J]. Semin Nephrol, 1989, 9:65-71
  • 7Kurz P, Monier Faugere MC, Bognar B, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease[J]. Kidney Int, 1994, 46:855-861
  • 8Nakano Y, Oshima T, Sasaki S, et al. Vitamin D receptor gene polymorphism is associated with serum total and ionized calcium concentration[J]. J Mol Med, 2000, 78:575-579
  • 9Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calciumХphosphorus product with mortality risk in chronic hemodialysis patients: a national study[J]. Am J Kidney Dis, 1998, 31: 607-617
  • 10Amann K, Gross ML, London GM, et al. Hyperphosphataemia-a silent killer of patients with renal failure[J]? Nephrol Dial Transplant, 1999, 14:2085-2087

共引文献809

同被引文献24

引证文献2

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部